![](https://bionapcfa.com/wp-content/uploads/2016/11/Table-1-250x190.png)
ASH Abstract Confirms Positive Outlook For Actinium’s Actimab-A
Last week, the American Society of Hematology (ASH) released abstracts for the upcoming 58th Annual Meeting & Exposition to be held December 3-6, 2016 in San Diego, CA. Included as part of the release was abstract #4050 from Actinium Pharmaceuticals, Inc. (NYSEMKT: ATNM). The abstract highlights the company’s Phase 1 clinical results with Actimab-A for the…